Sunday, February 02, 2020 9:45:27 AM
But can it core A apple?
Yes Ralph, of course it can core A apple.
Recent GRTX News
- Galera Adopts Limited Duration Stockholder Rights Agreement • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates • GlobeNewswire Inc. • 03/28/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:06:04 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/20/2024 11:57:58 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 11:11:39 PM
- Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates • GlobeNewswire Inc. • 11/14/2023 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/13/2023 07:24:56 PM
- Galera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 Trial • Dow Jones News • 10/31/2023 12:09:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 11:10:53 AM
- Galera Announces Receipt of Type A Meeting Minutes and Strategic Update • GlobeNewswire Inc. • 10/31/2023 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 11:24:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 09:12:53 PM
- Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem • GlobeNewswire Inc. • 09/18/2023 11:00:00 AM
- Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/05/2023 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:30:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:10:28 AM
- Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates • GlobeNewswire Inc. • 08/14/2023 11:00:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 12:00:58 PM
- Stocks to Watch: Applovin, Disney, Galera Therapeutics • Dow Jones News • 08/10/2023 12:10:00 AM
- Galera Therapeutics to Reduce Workforce by 70% to Extend Cash Runway • Dow Jones News • 08/09/2023 09:23:00 PM
- Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese • GlobeNewswire Inc. • 08/09/2023 08:31:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 08:11:02 PM
- Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting • GlobeNewswire Inc. • 06/05/2023 06:15:00 PM
- Galera Therapeutics Gets Orphan Drug Designation for Rucosopasem • Dow Jones News • 05/18/2023 12:44:00 PM
- Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer • GlobeNewswire Inc. • 05/18/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM